Paterna Biosciences
PrivateLast Round
Series A
May 13, 2026
Total Funding Raised
$13.53M
Company Overview
Paterna Biosciences is a biotechnology company that develops in-vitro spermatogenesis (IVS) technology to treat male infertility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paterna Biosciences Comparables
Compare Paterna Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kallistem | 80% | |
| Ovelle Bio Corp. | 73% | |
| Conception | 73% | |
Paterna Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 13, 2026 | ||||
| Seed | Oct 28, 2024 | ||||
| Seed | Mar 14, 2024 | ||||
| Seed | Aug 31, 2023 |
Key People
Founding team and executive leadership
Paterna Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| e184 | Seed |
| Freya Ventures | Seed |
| Utah Innovation Fund | Seed |
| Seaside Ventures | Seed |
| Capita3 | Seed |
| SpringTide Ventures | Seed |
| Divergent Capital | Seed |
Paterna Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paterna Biosciences's valuation, stock price, and market status.